methyl L-phenylalaninate
Star0
Identification
- Generic Name
- methyl L-phenylalaninate
- DrugBank Accession Number
- DB06838
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 179.2157
Monoisotopic: 179.094628665 - Chemical Formula
- C10H13NO2
- Synonyms
- (S)-phenylalanine methyl ester
- Methyl 3-phenyl-L-alaninate
- Phenylalanine methyl ester
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UFimbrial protein Not Available Neisseria gonorrhoeae UProthrombin Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
- Kingdom
- Organic compounds
- Super Class
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- Sub Class
- Amino acids, peptides, and analogues
- Direct Parent
- Phenylalanine and derivatives
- Alternative Parents
- Alpha amino acid esters / Amphetamines and derivatives / Fatty acid esters / Aralkylamines / Methyl esters / Monocarboxylic acids and derivatives / Organopnictogen compounds / Organic oxides / Monoalkylamines / Hydrocarbon derivatives show 1 more
- Substituents
- Alpha-amino acid ester / Amine / Amphetamine or derivatives / Aralkylamine / Aromatic homomonocyclic compound / Benzenoid / Carbonyl group / Carboxylic acid ester / Fatty acid ester / Fatty acyl show 13 more
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- alpha-amino acid ester, L-phenylalanine derivative (CHEBI:49339)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 10AT497I17
- CAS number
- 2577-90-4
- InChI Key
- VSDUZFOSJDMAFZ-VIFPVBQESA-N
- InChI
- InChI=1S/C10H13NO2/c1-13-10(12)9(11)7-8-5-3-2-4-6-8/h2-6,9H,7,11H2,1H3/t9-/m0/s1
- IUPAC Name
- methyl (2S)-2-amino-3-phenylpropanoate
- SMILES
- COC(=O)[C@@H](N)CC1=CC=CC=C1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 736234
- PubChem Substance
- 99443309
- ChemSpider
- 643364
- ChEBI
- 49339
- ChEMBL
- CHEMBL51969
- ZINC
- ZINC000019419113
- PDBe Ligand
- 0A9
- PDB Entries
- 3qgo / 3qh5 / 4y38 / 6sc3 / 8gvd / 8gvy
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 3.11 mg/mL ALOGPS logP 0.8 ALOGPS logP 1.22 Chemaxon logS -1.8 ALOGPS pKa (Strongest Basic) 6.97 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 52.32 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 49.89 m3·mol-1 Chemaxon Polarizability 19.38 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9936 Blood Brain Barrier + 0.9263 Caco-2 permeable + 0.7665 P-glycoprotein substrate Non-substrate 0.7454 P-glycoprotein inhibitor I Non-inhibitor 0.9504 P-glycoprotein inhibitor II Non-inhibitor 0.9606 Renal organic cation transporter Non-inhibitor 0.8382 CYP450 2C9 substrate Non-substrate 0.8077 CYP450 2D6 substrate Non-substrate 0.6824 CYP450 3A4 substrate Non-substrate 0.7313 CYP450 1A2 substrate Non-inhibitor 0.5898 CYP450 2C9 inhibitor Non-inhibitor 0.9806 CYP450 2D6 inhibitor Non-inhibitor 0.9182 CYP450 2C19 inhibitor Non-inhibitor 0.9656 CYP450 3A4 inhibitor Non-inhibitor 0.9546 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9075 Ames test Non AMES toxic 0.9493 Carcinogenicity Non-carcinogens 0.8018 Biodegradation Ready biodegradable 0.5863 Rat acute toxicity 2.2152 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9662 hERG inhibition (predictor II) Non-inhibitor 0.9467
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 146.1944959 predictedDarkChem Lite v0.1.0 [M-H]- 134.2689 predictedDeepCCS 1.0 (2019) [M+H]+ 146.3631959 predictedDarkChem Lite v0.1.0 [M+H]+ 136.6645 predictedDeepCCS 1.0 (2019) [M+Na]+ 146.5890959 predictedDarkChem Lite v0.1.0 [M+Na]+ 142.95676 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsFimbrial protein
- Kind
- Protein
- Organism
- Neisseria gonorrhoeae
- Pharmacological action
- Unknown
- General Function
- Not Available
- Specific Function
- This protein is the predominant Neisseria surface antigen, which allows adhesion of the bacterium to various host cells.
- Gene Name
- pilE1
- Uniprot ID
- P02974
- Uniprot Name
- Fimbrial protein
- Molecular Weight
- 17944.29 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
2. DetailsProthrombin
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Thrombospondin receptor activity
- Specific Function
- Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostas...
- Gene Name
- F2
- Uniprot ID
- P00734
- Uniprot Name
- Prothrombin
- Molecular Weight
- 70036.295 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:17 / Updated at June 12, 2020 16:52